246 related articles for article (PubMed ID: 22535620)
1. A global perspective on sickle cell disease.
Aygun B; Odame I
Pediatr Blood Cancer; 2012 Aug; 59(2):386-90. PubMed ID: 22535620
[TBL] [Abstract][Full Text] [Related]
2. Sickle cell disease in sub-Saharan Africa: stakes and strategies for control of the disease.
Diallo DA; Guindo A
Curr Opin Hematol; 2014 May; 21(3):210-4. PubMed ID: 24613937
[TBL] [Abstract][Full Text] [Related]
3. Bridging the Access Gap for Comprehensive Sickle Cell Disease Management Across Sub-Saharan Africa: Learnings for Other Global Health Interventions?
Hegemann L; Narasimhan V; Marfo K; Kuma-Aboagye P; Ofori-Acquah S; Odame I
Ann Glob Health; 2023; 89(1):76. PubMed ID: 38025926
[TBL] [Abstract][Full Text] [Related]
4. Sickle cell disease: Translating clinical care to low-resource countries through international research collaborations.
Smart LR; Hernandez AG; Ware RE
Semin Hematol; 2018 Apr; 55(2):102-112. PubMed ID: 30616806
[TBL] [Abstract][Full Text] [Related]
5. Neonatal screening and clinical care programmes for sickle cell disorders in sub-Saharan Africa: lessons from pilot studies.
Tshilolo L; Kafando E; Sawadogo M; Cotton F; Vertongen F; Ferster A; Gulbis B
Public Health; 2008 Sep; 122(9):933-41. PubMed ID: 18555498
[TBL] [Abstract][Full Text] [Related]
6. Severity in phenotypic expression of homozygous sickle cell disease (Hb.SS)--does hypermelanotic or hypomelanotic skin status of affected patients play a role?
Bakare MO
Med Hypotheses; 2011 May; 76(5):673-5. PubMed ID: 21288648
[TBL] [Abstract][Full Text] [Related]
7. Caring for Africa's sickle cell children: will we rise to the challenge?
Oron AP; Chao DL; Ezeanolue EE; Ezenwa LN; Piel FB; Ojogun OT; Uyoga S; Williams TN; Nnodu OE
BMC Med; 2020 Apr; 18(1):92. PubMed ID: 32340612
[TBL] [Abstract][Full Text] [Related]
8. Sickle cell disease in Africa: an overview of the integrated approach to health, research, education and advocacy in Tanzania, 2004-2016.
Tluway F; Makani J
Br J Haematol; 2017 Jun; 177(6):919-929. PubMed ID: 28295224
[TBL] [Abstract][Full Text] [Related]
9. Developing a global agenda for sickle cell disease: report of an international symposium and workshop in Cotonou, Republic of Benin.
Odame I
Am J Prev Med; 2010 Apr; 38(4 Suppl):S571-5. PubMed ID: 20331960
[TBL] [Abstract][Full Text] [Related]
10. Sickle cell disease: Reducing the global disease burden.
Mburu J; Odame I
Int J Lab Hematol; 2019 May; 41 Suppl 1():82-88. PubMed ID: 31069977
[TBL] [Abstract][Full Text] [Related]
11. Current understanding in the management of sickle cell disease.
Inati A; Chabtini L; Mounayar M; Taher A
Hemoglobin; 2009; 33 Suppl 1():S107-15. PubMed ID: 20001613
[TBL] [Abstract][Full Text] [Related]
12. Sickle cell disease: current activities, public health implications, and future directions.
Creary M; Williamson D; Kulkarni R
J Womens Health (Larchmt); 2007 Jun; 16(5):575-82. PubMed ID: 17627395
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology and treatment of relative anemia in children with sickle cell disease in sub-Saharan Africa.
Bello-Manga H; DeBaun MR; Kassim AA
Expert Rev Hematol; 2016 Nov; 9(11):1031-1042. PubMed ID: 27677923
[TBL] [Abstract][Full Text] [Related]
14. Emergency management of sickle cell disease complications: review and practice guidelines.
Hick JL; Nelson SC; Hick K; Nwaneri MO
Minn Med; 2006 Feb; 89(2):42-4, 47. PubMed ID: 16700347
[TBL] [Abstract][Full Text] [Related]
15. Genetic Blood Disorders Survey in the Sultanate of Oman.
Al-Riyami A; Ebrahim GJ
J Trop Pediatr; 2003 Jul; 49 Suppl 1():i1-20. PubMed ID: 12934793
[TBL] [Abstract][Full Text] [Related]
16. The cost of health care for children and adults with sickle cell disease.
Kauf TL; Coates TD; Huazhi L; Mody-Patel N; Hartzema AG
Am J Hematol; 2009 Jun; 84(6):323-7. PubMed ID: 19358302
[TBL] [Abstract][Full Text] [Related]
17. Conquering the intolerable burden of malaria: what's new, what's needed: a summary.
Breman JG; Alilio MS; Mills A
Am J Trop Med Hyg; 2004 Aug; 71(2 Suppl):1-15. PubMed ID: 15331814
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and management of sickle cell disorders.
Mousa SA; Qari MH
Methods Mol Biol; 2010; 663():291-307. PubMed ID: 20617425
[TBL] [Abstract][Full Text] [Related]
19. Management of painful vaso-occlusive crisis of sickle-cell anemia: consensus opinion.
Mousa SA; Al Momen A; Al Sayegh F; Al Jaouni S; Nasrullah Z; Al Saeed H; Alabdullatif A; Al Sayegh M; Al Zahrani H; Hegazi M; Al Mohamadi A; Alsulaiman A; Omer A; Al Kindi S; Tarawa A; Al Othman F; Qari M
Clin Appl Thromb Hemost; 2010 Aug; 16(4):365-76. PubMed ID: 20530056
[TBL] [Abstract][Full Text] [Related]
20. Implementation science research for the scale-up of evidence-based interventions for sickle cell disease in africa: a commentary.
Gyamfi J; Ojo T; Iwelunmor J; Ogedegbe G; Ryan N; Diawara A; Nnodu O; Wonkam A; Royal C; Peprah E
Global Health; 2021 Feb; 17(1):20. PubMed ID: 33596947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
